Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 3,500 INR
Change Today -31.75 / -0.90%
Volume 9.8K
As of 4:45 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for glaxosmithkline pharmaceutic (GLXO)

View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Dec 31
2011
Restated
INR
Dec 31
2012
Reclassified
INR
Dec 31
2013
INR
Mar 31
2015
Press
Release

INR
4 Year
Trend
Revenues23,784.826,214.125,383.426,179.8
Other Revenues345.5232.9213.3256.3
TOTAL REVENUES24,130.226,447.025,596.726,436.1
Cost of Goods Sold10,206.712,189.613,133.712,083.5
GROSS PROFIT13,923.614,257.412,462.914,352.6
Selling General & Admin Expenses, Total5,349.65,696.76,605.03,944.2
Depreciation & Amortization, Total204.1178.4198.8202.8
Other Operating Expenses488.6254.8473.15,344.6
OTHER OPERATING EXPENSES, TOTAL6,042.36,129.97,276.99,491.5
OPERATING INCOME7,881.38,127.55,186.04,861.0
Interest Expense-3.3-3.3-3.3--
Interest and Investment Income1,453.11,746.41,744.7--
NET INTEREST EXPENSE1,449.81,743.11,741.4--
Currency Exchange Gains (Loss)-60.8-46.6-91.8--
Other Non-Operating Income (Expenses)1.8----1,599.4
EBT, EXCLUDING UNUSUAL ITEMS9,272.19,824.06,835.66,460.5
Merger & Restructuring Charges-234.1-1,347.0-21.8--
Gain (Loss) on Sale of Investments1.2--0.9--
Gain (Loss) on Sale of Assets--1.816.5--
Other Unusual Items, Total-2,991.4-135.2283.4-415.0
Other Unusual Items-2,991.4-135.2283.4-415.0
EBT, INCLUDING UNUSUAL ITEMS6,047.98,343.67,114.56,045.4
Income Tax Expense1,762.02,724.82,297.82,234.2
Earnings from Continuing Operations4,285.95,618.84,816.73,811.3
NET INCOME4,285.95,618.84,816.73,811.3
NET INCOME TO COMMON INCLUDING EXTRA ITEMS4,285.95,618.84,816.73,811.3
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS4,285.95,618.84,816.73,811.3
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLXO:IN 3,500.00 INR -31.75

GLXO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GLXO.
View Industry Companies
 

Industry Analysis

GLXO

Industry Average

Valuation GLXO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PHARMACEUTIC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.